Literature DB >> 7869206

Neonatal mortality rate: is further improvement possible?

A G Philip1.   

Abstract

OBJECTIVE: To determine whether improvement in neonatal and infant mortality rates is possible or likely.
SETTING: Regional neonatal intensive care unit.
METHODS: Experience during a decade (1982-1991) was evaluated. We determined postnatal age at death and birth weight-specific and gestational age-specific mortality rates. Neonatal deaths (deaths before discharge) were categorized as "possibly preventable" or "probably unpreventable."
RESULTS: Deaths occurring after 28 days ("postponed" deaths) contributed 9% of the total for the decade, and 5% for those with extremely low birth weight (ELBW; < 1000 gm) during the last 6 years; 47% of all deaths and 65% of deaths of ELBW infants occurred within 24 hours of birth. Congenital malformations accounted for 7%, 54%, and 66% of deaths when birth weight was 500 to 1499 gm, 1500 to 2499 gm, and > or = 2500 gm, respectively. In infants with birth weight > or = 1000 gm, probably unpreventable deaths (predominantly from congenital malformations, but also including hydrops and inborn errors of metabolism) accounted for 61% of deaths. Of deaths of ELBW infants, extreme prematurity (500 to 750 gm) accounted for 58%; major malformations and pulmonary hypoplasia contributed an additional 9%.
CONCLUSION: During the decade, the gestational age at which there was a 50% survival rate fell from 26 weeks to 24 weeks and a marked increase in the survival rate occurred at birth weights < 1500 gm (VLBW) after the introduction of exogenous surfactant therapy. The number of possibly preventable deaths is now very small. For any substantial impact on mortality rates, it will be necessary to lower VLBW and ELBW rates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869206     DOI: 10.1016/s0022-3476(95)70463-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  A murine model for the study of Chlamydia trachomatis genital infections during pregnancy.

Authors:  S Pal; E M Peterson; L M De La Maza
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Initial treatment of preterm infants--continuous positive airway pressure or ventilation?

Authors:  K E Lundstrøm
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

3.  Improved outcome for infants at the limits of viability.

Authors:  R W Cooke
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 4.  Perinatal management at the lower margin of viability.

Authors:  J M Rennie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

Review 5.  Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Cindy T McEvoy; Lucky Jain; Barbara Schmidt; Steven Abman; Eduardo Bancalari; Judy L Aschner
Journal:  Ann Am Thorac Soc       Date:  2014-04

6.  Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era.

Authors:  S R Hintz; W K Poole; L L Wright; A A Fanaroff; D E Kendrick; A R Laptook; R Goldberg; S Duara; B J Stoll; W Oh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

7.  Strategies for reduction of neonatal mortality.

Authors:  A Finan; T A Clarke; T G Matthews; M Ledwidge; J Gillan; C Barry-Kinsella; P McKenna
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

Review 8.  Evidence of selection bias in preterm survival studies: a systematic review.

Authors:  D J Evans; M I Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

9.  Trends and racial differences in birth weight and related survival.

Authors:  G R Alexander; M E Tompkins; M C Allen; T C Hulsey
Journal:  Matern Child Health J       Date:  1999-06

10.  Antioxidant activity, packed cell transfusions, and outcome in premature infants.

Authors:  K M Silvers; A T Gibson; J M Russell; H J Powers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.